MCID: VRL005
MIFTS: 42

Viral Pneumonia

Categories: Respiratory diseases, Infectious diseases

Aliases & Classifications for Viral Pneumonia

MalaCards integrated aliases for Viral Pneumonia:

Name: Viral Pneumonia 12 14
Pneumonia, Viral 42 69

Classifications:



External Ids:

Disease Ontology 12 DOID:10533
ICD10 33 J12.9 J12
ICD9CM 35 480 480.9
MeSH 42 D011024
UMLS 69 C0032310

Summaries for Viral Pneumonia

Disease Ontology : 12 A pneumonia described as an inflammatory illness of the lung commonly caused by viruses such as influenza virus, parainfluenza, adenovirus, rhinovirus, herpes simplex virus, respiratory syncytial virus, hantavirus, and cytomegalovirus.

MalaCards based summary : Viral Pneumonia, also known as pneumonia, viral, is related to malaria and pneumonia. An important gene associated with Viral Pneumonia is NSMCE3 (NSE3 Homolog, SMC5-SMC6 Complex Component), and among its related pathways/superpathways are Innate Immune System and T cell receptor signaling pathway. The drugs Oseltamivir and Azithromycin have been mentioned in the context of this disorder. Affiliated tissues include lung, bone and bone marrow.

Wikipedia : 72 Viral pneumonia is a pneumonia caused by a virus. Viruses are one of the two major causes of pneumonia,... more...

Related Diseases for Viral Pneumonia

Diseases in the Pneumonia family:

Viral Pneumonia

Diseases related to Viral Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 134)
id Related Disease Score Top Affiliating Genes
1 malaria 28.0 CR1 CRP IL17A IL6 TLR9
2 pneumonia 11.3
3 influenza 11.2
4 lung disease, immunodeficiency, and chromosome breakage syndrome 10.8
5 collagenopathy type 2 alpha 1 10.7 CRP IL6
6 crystal arthropathies 10.6 CRP IL6
7 shoulder impingement syndrome 10.6 CRP IL6
8 brachydactyly-distal symphalangism syndrome 10.6 CRP IL6
9 epstein-barr virus hepatitis 10.6 CRP IL6
10 x-linked dominant intellectual disability-epilepsy syndrome 10.6 CRP IL6
11 erythema elevatum diutinum 10.6 CRP IL6
12 chronic diarrhea due to guanylate cyclase 2c overactivity 10.6 CRP IL6
13 nodular nonsuppurative panniculitis 10.6 CRP IL6
14 hemangioma of spleen 10.6 CRP IL6
15 lung occult large cell carcinoma 10.6 CRP IL6
16 cicatricial lagophthalmos 10.6 CRP IL6
17 ariboflavinosis 10.6 CRP IL6
18 multiple congenital anomalies mental retardation, growth failure and cleft lip palate 10.6 CRP IL6
19 islet cell tumor 10.6 CRP IL6
20 queensland tick typhus 10.6 CRP IL6
21 placental abruption 10.6 CRP IL6
22 luxation of globe 10.6 CRP IL6
23 parasitic helminthiasis infectious disease 10.6 CRP IL6
24 allergic bronchopulmonary aspergillosis 10.6 CRP IL6
25 benign neonatal seizures 10.6 CRP IL6
26 hyperlipoproteinemia type iv 10.6 CRP IL6
27 partial central choroid dystrophy 10.6 CRP IL6
28 breast papillary carcinoma 10.6 CRP IL6
29 pneumoconiosis 10.6 CRP IL6
30 plummer's disease 10.6 CRP IL6
31 residual stage corticosteroid-induced glaucoma 10.6 CRP IL6
32 cryptogenic organizing pneumonia 10.5 CRP IL17A
33 bardet-biedl syndrome 8 10.5 CRP IL6
34 brain glioblastoma multiforme 10.5 CRP IL6
35 focal dystonia 10.5 CRP IL6
36 diffuse glomerulonephritis 10.5 CR1 IL6
37 ischemic heart disease 10.5 CRP IL6
38 urinary bladder posterior wall cancer 10.5 CRP IL6
39 atrophy of prostate 10.5 CRP IL6
40 tricho onychic dysplasia 10.5 IL17A IL6
41 chondroma 10.5 CRP IL6
42 colonic disease 10.5 CRP IL6
43 myofascial pain syndrome 10.5 IL17A IL6
44 pancreas lymphoma 10.5 CRP IL6
45 tracheal stenosis 10.5 IL17A IL6
46 cytomegalovirus disease in patients with impaired cell mediated immunity deemed at risk 10.5 IL17A IL6
47 keloids 10.5 IL17A IL6
48 esophagus melanoma 10.5 CRP IL6
49 choroiditis 10.5 CRP IL6
50 gastroduodenal crohn's disease 10.5 IL17A IL6

Comorbidity relations with Viral Pneumonia via Phenotypic Disease Network (PDN):


Acute Cystitis Bronchitis
Chronic Myocardial Ischemia Deficiency Anemia
Familial Atrial Fibrillation Heart Disease
Hypothyroidism Ischemic Heart Disease
Postinflammatory Pulmonary Fibrosis Respiratory Failure

Graphical network of the top 20 diseases related to Viral Pneumonia:



Diseases related to Viral Pneumonia

Symptoms & Phenotypes for Viral Pneumonia

Drugs & Therapeutics for Viral Pneumonia

Drugs for Viral Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 291)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oseltamivir Approved Phase 4,Phase 3,Phase 1,Phase 2 204255-11-8, 196618-13-0 65028
2
Azithromycin Approved Phase 4,Phase 2 83905-01-5 55185 53477736 447043
3
Ribavirin Approved Phase 4,Phase 3,Phase 1,Phase 2 36791-04-5 37542
4
Abacavir Approved, Investigational Phase 4 136470-78-5 65140 441300
5
Efavirenz Approved, Investigational Phase 4,Phase 1 154598-52-4 64139
6
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
7
Nevirapine Approved Phase 4 129618-40-2 4463
8
Sulfamethoxazole Approved Phase 4,Phase 3,Phase 2,Phase 1 723-46-6 5329
9
Trimethoprim Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 738-70-5 5578
10
Zidovudine Approved Phase 4,Phase 3,Phase 2,Phase 1 30516-87-1 35370
11
Lopinavir Approved Phase 4 192725-17-0 92727
12
Ritonavir Approved, Investigational Phase 4,Phase 1 155213-67-5 392622
13
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
14
Atovaquone Approved Phase 4,Phase 3,Phase 2,Phase 1 95233-18-4 74989
15
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
16
Dapsone Approved, Investigational Phase 4,Phase 3,Phase 1 80-08-0 2955
17
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
18
Pentamidine Approved Phase 4,Phase 3,Phase 2,Phase 1 100-33-4 4735
19
Primaquine Approved Phase 4 90-34-6 4908
20
Ganciclovir Approved, Investigational Phase 4 82410-32-0 3454
21
Prednisone Approved, Vet_approved Phase 4,Phase 2 53-03-2 5865
22
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
23
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
24
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1 58-05-9 143 6006
25 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
26 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
27 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
28 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
29 Antitubercular Agents Phase 4,Phase 2,Phase 3
30 Heptavalent Pneumococcal Conjugate Vaccine Phase 4,Phase 3,Phase 2,Phase 1
31 Vaccines Phase 4,Phase 3,Phase 2,Phase 1
32 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
33 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
34 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1
35 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
36 MF59 oil emulsion Phase 4
37 Anti-HIV Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Antimalarials Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
40 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
41 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1
42
Bilirubin Phase 4 635-65-4 5280352
43 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 1
44 Cytochrome P-450 CYP3A Inducers Phase 4,Phase 2,Phase 1
45 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
46 Dideoxynucleosides Phase 4
47 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1
48 Lamivudine, zidovudine drug combination Phase 4
49 N-Methylaspartate Phase 4
50 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 224)

id Name Status NCT ID Phase Drugs
1 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
2 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
3 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
4 Influenza Vaccine in HIV Infected Children Completed NCT00883012 Phase 4
5 Prevention of RSV Infections in Bone Marrow Transplant Recipients Completed NCT00001903 Phase 4 RSV Polyclonal Immunoglobulin
6 Rapid Empiric Treatment With Oseltamivir Study (RETOS) Completed NCT01248715 Phase 4 oseltamivir
7 Intermittent Use of Aerosolized Ribavirin for Treatment of RSV Completed NCT00500578 Phase 4 Ribavirin;Ribavirin
8 Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections Completed NCT01779570 Phase 4 Macrolide treatment
9 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
10 Adjuvanted Influenza Vaccine in Stem Cell Transplant Completed NCT02560909 Phase 4
11 Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection Completed NCT00371878 Phase 4
12 Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) Completed NCT00312858 Phase 4
13 Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa Completed NCT02028676 Phase 4 Arm A: ABC+3TC+NNRTI;Arm B: ZDV+ABC+3TC+NNRTI->ABC+3TC+NNRTI maintenance;Arm C: ZDV+ABC+3TC+NNRTI->ZDV+ABC+3TC maintenance;Once-daily ABC+3TC;Twice-daily ABC+3TC;Continued cotrimoxazole prophylaxis
14 AZithromycin Against pLacebo in Exacerbations of Asthma Completed NCT01444469 Phase 4 Zithromax;Placebo
15 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa Completed NCT01088516 Phase 4 Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
16 Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis Completed NCT00000816 Phase 4 Sulfamethoxazole-Trimethoprim
17 PTH - Preemptive Treatment for Herpesviridae Recruiting NCT02152358 Phase 4 Aciclovir;Ganciclovir;Placebo
18 Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Recruiting NCT03087890 Phase 4 Cotrimoxazole;Placebo
19 Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia Active, not recruiting NCT02258763 Phase 4 Amoxicillin-Potassium Clavulanate Combination;Placebo
20 A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia Not yet recruiting NCT02972957 Phase 4 Azithromycin
21 Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) Terminated NCT00687544 Phase 4 Ribavirin (SCH 018908)
22 Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) Withdrawn NCT00636935 Phase 4 Antibiotics only;Antibiotics + Corticosteroids;Corticosteroids + antibiotics
23 Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial Completed NCT01868113 Phase 3 Inhaled corticosteroid
24 Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation Completed NCT00016081 Phase 3 ribavirin
25 Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze Completed NCT00407394 Phase 3 Amoxycillin
26 Oseltamivir Randomised Controlled Efficacy Trial Completed NCT00707941 Phase 3 Oseltamivir;Placebo
27 Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR Completed NCT00275691 Phase 2, Phase 3
28 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
29 Maternal Vitamin D for Acute Respiratory Infections in Infancy Completed NCT02388516 Phase 3
30 Flu Vaccine Against Childhood Pneumonia, Bangladesh Completed NCT01319955 Phase 3
31 Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. Completed NCT00829010 Phase 3
32 A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh Completed NCT01797029 Phase 3
33 Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection Completed NCT00098046 Phase 3 famciclovir
34 COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine Completed NCT00466947 Phase 3
35 V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) Completed NCT00109343 Phase 3
36 CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia Completed NCT00148733 Phase 2, Phase 3 Zinc
37 A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP Completed NCT00000700 Phase 3 Zidovudine
38 A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older Completed NCT02710409 Phase 3
39 Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine Completed NCT01580033 Phase 3
40 Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children Completed NCT01428908 Phase 3
41 Efficacy of Zinc in the Treatment of Bronchiolitis and Prevention of Wheezing Respiratory Illness in Children Less Than Two Years Old Completed NCT00355043 Phase 3 Zinc sulphate 20 mg
42 Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza Completed NCT00192413 Phase 3
43 A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months Completed NCT01000311 Phase 3
44 A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX Completed NCT00002340 Phase 3 Atovaquone;Pentamidine isethionate
45 Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Completed NCT00001013 Phase 3 Trimetrexate glucuronate;Pentamidine isethionate;Sulfamethoxazole-Trimethoprim;Leucovorin calcium
46 A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia Completed NCT00000724 Phase 3 Trimetrexate glucuronate;Leucovorin calcium
47 A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies Completed NCT00001016 Phase 3 Trimetrexate glucuronate;Leucovorin calcium
48 A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS Completed NCT00000715 Phase 3 Pentamidine isethionate;Sulfamethoxazole-Trimethoprim
49 Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Completed NCT00001014 Phase 3 Trimetrexate glucuronate;Sulfamethoxazole-Trimethoprim;Leucovorin calcium
50 A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) Completed NCT00000727 Phase 3 Pentamidine isethionate;Pyrimethamine;Sulfamethoxazole/Trimethoprim;Sulfadoxine/Pyrimethamine;Zidovudine

Search NIH Clinical Center for Viral Pneumonia

Cochrane evidence based reviews: pneumonia, viral

Genetic Tests for Viral Pneumonia

Anatomical Context for Viral Pneumonia

MalaCards organs/tissues related to Viral Pneumonia:

39
Lung, Bone, Bone Marrow, Testes, Neutrophil, T Cells, B Cells

Publications for Viral Pneumonia

Articles related to Viral Pneumonia:

(show top 50) (show all 151)
id Title Authors Year
1
Secondary organizing pneumonia following viral pneumonia caused by severe influenza B: a case report and literature reviews. ( 28810835 )
2017
2
Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies. ( 28477640 )
2017
3
Severe viral pneumonia in adults: what is important for the ICU physician? ( 28633583 )
2017
4
Bacterial and viral pneumonia: New insights from the Drakenstein Child Health Study. ( 28687247 )
2017
5
Vaccines in the Prevention of Viral Pneumonia. ( 28159157 )
2017
6
Does atopy affect the course of viral pneumonia? ( 28634031 )
2017
7
Viral Pneumonia and Acute Respiratory Distress Syndrome. ( 28159154 )
2017
8
Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. ( 28464462 )
2017
9
Epidemiology of Viral Pneumonia. ( 28159152 )
2017
10
Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation. ( 28159165 )
2017
11
Retrospective review of epidemic viral pneumonia cases in Turkey: A multicenter study. ( 28413489 )
2017
12
Protective effects of Yinhuapinggan granule on mice with influenza viral pneumonia. ( 26655878 )
2016
13
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. ( 26934144 )
2016
14
Graft Loss and Clad Onset is Hastened by Viral Pneumonia After Lung Transplantation. ( 27467538 )
2016
15
Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study. ( 26683973 )
2015
16
Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia. ( 25957460 )
2015
17
The Serum Value of NO and IL-17 were Increased in Children with Influenza A Viral Pneumonia. ( 26642702 )
2015
18
CAUSATIVE AGENTS OF SEVERE COMMUNITY ACQUIRED VIRAL PNEUMONIA AMONG CHILDREN IN EASTERN THAILAND. ( 26867384 )
2015
19
Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. ( 26577540 )
2015
20
Epidemiology, etiology, x-ray features, importance of co-infections and clinical features of viral pneumonia in developing countries. ( 24410617 )
2014
21
Combination therapy with hepatocyte growth factor and oseltamivir confers enhanced protection against influenza viral pneumonia. ( 24894172 )
2014
22
Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia. ( 25089913 )
2014
23
Viral pneumonia in severe respiratory failure. ( 24602995 )
2014
24
Predictors of viral pneumonia in patients with community-acquired pneumonia. ( 25531901 )
2014
25
Aging exacerbates damage and delays repair of alveolar epithelia following influenza viral pneumonia. ( 25265939 )
2014
26
A Patient who Survived Primary Seasonal Influenza Viral Pneumonia: Histologic Findings Obtained via Bronchoscopy. ( 24334588 )
2013
27
Predictors of viral pneumonia: the need for viral testing in all patients hospitalized for nursing home-acquired pneumonia. ( 23441872 )
2013
28
Effect of the Haoqinqingdan decoction on damp-heat syndrome in rats with influenza viral pneumonia. ( 23790339 )
2013
29
H7N9 viral pneumonia: asymmetric and irregular changes on computed tomography. ( 24342341 )
2013
30
Are statins beneficial for viral pneumonia? ( 23633609 )
2013
31
Influenza and endemic viral pneumonia. ( 24094391 )
2013
32
Gravity-dependent opacity in pure influenza viral pneumonia. ( 23370759 )
2013
33
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia. ( 24380719 )
2013
34
Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia. ( 23344833 )
2013
35
Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. ( 22491448 )
2012
36
Clinical significance of pleural effusion in the new influenza A (H1N1) viral pneumonia in children and adolescent. ( 22028096 )
2012
37
Radiological findings in 210 paediatric patients with viral pneumonia: a retrospective case study. ( 22514104 )
2012
38
Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. ( 22996662 )
2012
39
Comparison of initial high resolution computed tomography features in viral pneumonia between metapneumovirus infection and severe acute respiratory syndrome. ( 21439753 )
2012
40
Con: corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. ( 21531953 )
2011
41
Viral pneumonia. ( 21435708 )
2011
42
ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. ( 22072972 )
2011
43
Angioembolisation of pulmonary artery pseudoaneurysm arising in H1N1 influenza viral pneumonia. ( 21315652 )
2011
44
Epidemic viral pneumonia and other emerging pathogens. ( 21867815 )
2011
45
Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia. ( 21668682 )
2011
46
Confirmed swine-origin influenza A(H1N1) viral pneumonia: computed tomographic findings in the immunocompetent and the immunocompromised. ( 21926856 )
2011
47
Acute kidney injury in critically ill patients with 2009 influenzaA A (H1N1) viral pneumonia: an observational study. ( 21394630 )
2011
48
Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus. ( 20805786 )
2011
49
H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. ( 21157318 )
2011
50
Clinical characteristics and computed tomography findings in children with 2009 pandemic influenza A (H1N1) viral pneumonia. ( 20854219 )
2011

Variations for Viral Pneumonia

Expression for Viral Pneumonia

Search GEO for disease gene expression data for Viral Pneumonia.

Pathways for Viral Pneumonia

GO Terms for Viral Pneumonia

Cellular components related to Viral Pneumonia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.8 FCRL6 IL17A IL6

Biological processes related to Viral Pneumonia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of interleukin-6 production GO:0032755 9.32 IL6 TLR9
2 acute-phase response GO:0006953 9.26 CRP IL6
3 inflammatory response GO:0006954 9.26 CRP IL17A IL6 TLR9
4 positive regulation of chemokine production GO:0032722 9.16 IL6 TLR9
5 negative regulation of lipid storage GO:0010888 8.62 CRP IL6

Sources for Viral Pneumonia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....